EU ATMP Developers Missing Out By Failing To Use Advice On Offer
Executive Summary
Regulators and health technology assessment officials in the EU are disappointed that sponsors of advanced therapy medicinal products are not making good use of the joint scientific advice service, which can help converge regulatory and HTA requirements for these products.